Watchlist
Loading...
US Stock MarketDetailed Quotes

BLCO Bausch + Lomb Corp.

Watchlist
16.580 -0.470-2.76% Trading 09/27 13:39 ET
17.140High16.510Low95.86KVolume
Intraday
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About Bausch + Lomb Corp. Company

Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.

Revenue Breakdown

Business Unit:USD
12/31/2022
Stock NameRevenueRatio
Vision Care2.37B62.98%
Surgical718M19.06%
Pharmaceuticals677M17.97%

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >